Navigation Links
Somanetics Corporation to Present at Rodman & Renshaw Annual Global Investment Conference
Date:11/3/2008

- Somanetics to Webcast Presentation on November 10, 2008 at 4:30 P.M. ET -

TROY, Mich., Nov. 3 /PRNewswire-FirstCall/ -- Somanetics Corporation (Nasdaq: SMTS) today announced it will present at the Rodman & Renshaw Annual Global Investment Conference at the New York Palace Hotel in New York. William Iacona, Somanetics' chief financial officer, will make a 25-minute presentation on Monday, November 10, 2008 at 4:30 p.m. ET. The presentation will be webcast live. The webcast may be accessed by visiting the Investor Center section of Somanetics' website at http://www.somanetics.com . The presentation also will be archived on Somanetics' website for 30 days following the conference.

About Somanetics

Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and markets the INVOS(R) Cerebral/Somatic Oximeter, a non-invasive patient monitoring system that continuously measures changes in the blood oxygen levels in the brain and elsewhere in the body in patients with or at risk for restricted blood flow. Surgeons, anesthesiologists and other medical professionals can use the information provided by the INVOS System, in conjunction with other available information, to identify oxygen imbalances in tissues beneath the sensor and take necessary corrective action, potentially improving patient outcomes and reducing the costs of care. The INVOS System has a nearly 11-year market track record supported by more than 600 clinical references, and is used at nearly 700 U.S. hospitals. Somanetics supports its customers through a direct U.S. sales force and clinical education team. Covidien markets INVOS System products in Europe, Canada, the Middle East and South Africa and Edwards Lifesciences represents INVOS System products in Japan. For more information visit http://www.somanetics.com .


'/>"/>
SOURCE Somanetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Somanetics Announces Share Repurchase Program Increased By $15 Million
2. Somanetics Receives 510(k) Clearance From the FDA to Expand INVOS System Labeling
3. Somanetics Corporation to Present at Citigroup 2008 Healthcare Conference
4. Somanetics Announces Share Repurchase Program Increased by $15 Million
5. Somanetics Announces Share Repurchase Program
6. Somanetics Reports Financial Results for the First Quarter of Fiscal 2008
7. Somanetics Corporation to Release First Quarter 2008 Financial Results and Host Conference Call March 18, 2008
8. Somanetics Corporation to Release Fourth Quarter and Fiscal 2007 Financial Results and Host Conference Call January 23, 2008
9. Somanetics Corporation to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
10. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
11. STERIS Corporation Announces Webcast of Analyst Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... PHILADELPHIA (PRWEB) , ... July 24, 2017 , ... ... Health , two organizations that already work hand-in-hand on an Innovation Collaboration program, ... transform the access, quality, experience and cost of the care members and patients ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... (adipose) transfer systems announces the issuance of United States Patent Number 9,695,398 (the ... adipose filtration technology. The '398 and '324 patents cover methods and systems ...
(Date:7/24/2017)... ... 24, 2017 , ... The 2017 NCSL International Workshop & ... focuses on the new ISO/IEC 17025 standards. This marks the first time in ... calibration will be changed. , As an exhibitor, METTLER TOLEDO will showcase ...
(Date:7/24/2017)... ... July 24, 2017 , ... A ... focused on delivering end-to-end sleep health care at scale, indicates record-breaking adherence ... that adherence rates for positive airway pressure (PAP) therapy, the most widely utilized ...
(Date:7/24/2017)... Calif. (PRWEB) , ... July 24, 2017 , ... A ... from food addiction to sexual abuse, and how she has overcome them. “Forbidden Memories: ... instances in her life and how she has risen above. , In “Memories,” readers ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... York City-based market research firm Kalorama Information notes seven trends ... new products to new costs, to the threat of generic ... Potential Pipeline Disruptors . Among them are ... Age-Driven Growth - True Impact Moment Arriving   ... growing population and, to a more extreme extent, the aging ...
(Date:7/11/2017)... , July 11, 2017  Bayer has awarded grants ... countries as part of its prestigious Bayer Hemophilia Awards Program ... of Philadelphia and Uniformed Services University ... are among the winners. Grant recipients were announced last night ... Hemostasis (ISTH) 2017 Congress, Berlin, Germany . ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
Breaking Medicine Technology: